发明名称 Treatment of metastatic cancer through mts-1 gene
摘要 The present invention is directed towards the diagnosis of malignant cancer by detection of the mts-1 MRNA or the <highlight><uline>mts-1</uline></highlight> protein, encoded by the <highlight><uline>mts-1</uline></highlight> gene. The present invention contemplates the use of recombinant mts-1 DNA and antibodie4 directed against the mts-1 protein to diagnose the metastatic potential of several types of tumor cells, including, for example, thyroid, epithelial, lung, liver and kidney tumor cells. The present invention is also directed to mammalian cell lines and tumors with high and low metastatic potential which have been developed to serve as tseful model systems for in vitro and in vivo anti-metastasis drug screening.
申请公布号 AU4369800(A) 申请公布日期 2000.11.10
申请号 AU20000043698 申请日期 2000.04.20
申请人 RESEARCH CORPORATION TECHNOLOGIES, INC. 发明人 EUGENE LUKANIDIN
分类号 A61K38/00;A61K47/48;A61P35/04;B60R21/16;B60R21/235;C07K14/47;C07K16/18;C07K16/30 主分类号 A61K38/00
代理机构 代理人
主权项
地址